Drug may reduce coronary artery plaque
Sunday, October 12, 2008 - 11:56
in Health & Medicine
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.
Read the whole article on Physorg
More from Physorg
Related
- Drug may reduce coronary artery plaqueSun, 12 Oct 2008, 12:56:41 EDT
- Vulnerable plaque may be easier to detect through new imaging technologySun, 12 Oct 2008, 12:56:35 EDT
- New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008Sun, 12 Oct 2008, 12:56:43 EDT
- Triple antiplatelet therapy appears superior to dual antiplatelet therapySun, 12 Oct 2008, 12:56:38 EDT
- Study reveals that signs of heart disease are attributed to stress more frequently in women than menSun, 12 Oct 2008, 12:56:46 EDT